Wang Zefeng, Zhang Heping, Peng Hui, Shen Xuhua, Sun Zhijun, Zhao Can, Dong Ruiqing, Gao Huikuan, Wu Yongquan
Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Clin Cardiol. 2016 Dec;39(12):733-738. doi: 10.1002/clc.22598.
Premature ventricular contractions (PVCs) from the right ventricular outflow tract (RVOT) can resist conventional mapping strategies. Studies regarding optimal mapping and ablation methods for patients with noninducible RVOT-PVCs are limited. We retrospectively evaluated the efficacy and safety of a novel mapping strategy for these cases: voltage mapping combined with pace mapping.
METHODS: We retrospectively included symptomatic patients (n = 148; 76 males; age, 44.5 ± 1.4 years) with drug-refractory PVCs originating from the RVOT, who underwent radiofrequency catheter ablation (RFCA), and stratified them as Group 1 and Group 2. Group 1 patients had noninducible RVOT-PVCs, determined after programmed stimulation, burst pacing, and isoproterenol infusion (n = 21; 12 males; age, 39.5 ± 10.8 years). Group 2 patients had inducible PVCs. Group 1 patients were subjected to voltage mapping combined with pace mapping; Group 2 underwent conventional mapping. In all patients prior to RFCA, detailed 3-dimensional electroanatomic voltage maps of the RVOT were obtained during sinus rhythm using the CARTO system.
Patients from both groups had similar success and complication rates associated with the RFCA. In Group 2, 89% (113/127) experienced the earliest and the successful ablation points in the voltage transitional zone. During the follow-up (36 ± 8 months), patients from both groups suffered similar rates of PVC relapse (2/21 and 7/127, respectively; P = 0.826).
Voltage mapping combined with pace mapping is effective and safe for patients with noninducible RVOT-PVCs determined by conventional methods.
源自右心室流出道(RVOT)的室性早搏(PVCs)可能难以用传统标测策略进行处理。关于非诱发性RVOT-PVCs患者的最佳标测和消融方法的研究有限。我们回顾性评估了针对这些病例的一种新型标测策略的疗效和安全性:电压标测联合起搏标测。
方法:我们回顾性纳入了有症状的、药物难治性RVOT源性PVCs且接受了射频导管消融(RFCA)的患者(n = 148;男性76例;年龄44.5±1.4岁),并将他们分为1组和2组。1组患者经程序刺激、短阵起搏和异丙肾上腺素输注后确定为非诱发性RVOT-PVCs(n = 21;男性12例;年龄39.5±10.8岁)。2组患者为诱发性PVCs。1组患者接受电压标测联合起搏标测;2组接受传统标测。在所有患者进行RFCA之前,使用CARTO系统在窦性心律期间获取RVOT详细的三维电解剖电压图。
两组患者与RFCA相关的成功率和并发症发生率相似。在2组中,89%(113/127)在电压过渡区出现最早且成功的消融点。在随访期间(36±8个月),两组患者的PVC复发率相似(分别为2/21和7/127;P = 0.826)。
对于通过传统方法确定为非诱发性RVOT-PVCs的患者,电压标测联合起搏标测是有效且安全的。